The Genus plc Board is recommending a final dividend of 24.0 pence per ordinary share representing growth of 11% on the prior year. When combined with the interim dividend, the total full year dividend of 35.2 pence per ordinary share represents growth of 10% (FY25: 32.0 pence per share). The full year dividend of 35.2 pence per share corresponds to a 32% payout of adjusted earnings per share which is consistent with the Group’s targeted payout range of 30% to 40% as described in the Group’s interim results statement published in February 2026.
It is proposed that the final dividend will be paid on 4 December 2026 to the shareholders on the register at the close of business on 13 November 2026.
Other financial highlights include:
- Adjusted operating profit growth of 25% including JVs, driven by strong PIC growth, a £5.6m milestone payment from the Group’s Chinese partner, Beijing Capital Agribusiness (“BCA”), and Value Acceleration Programme (“VAP”) actions benefitting ABS
- Adjusted profit before tax (PBT) increased 35%; excluding BCA milestones received in both FY26 and FY25, adjusted PBT increased 34%
- Statutory PBT of £310.5m increased significantly year on year due to a £204.1m gain from the 51% disposal of PIC China to form a strategic joint venture and an increase of £12.8m in the non-cash fair value IAS41 valuation of biological assets
- Adjusted earnings per share increased 35%
- Strong free cash generation of £62.0m (FY25: £40.9m)
- Leverage reduced significantly to 0.4x1 (30 June 2025: 1.5x), supported by strong free cash generation and £98m4 of net cash inflow from the 51% sale of PIC China into a joint venture
- Additional return of capital to shareholders; as announced separately today, £60m share buyback programme expected to be completed during FY27
